Over 100 speakers will join us
Below is a selection of speakers confirmed to present at INHSU 2023 in Geneva. To view the full program of over 100+ sessions dedicated to the health and well-being of people who use drugs, with tracks on epidemiology, public health, clinical research, and policy development, view the program.
Former President of the Swiss Confederation and founding member and former Chair of the Global Commission on Drug Policy.
Dr. Joaquin Cabezas
Gastroenterology and Hepatology Physician, Marques de Valdecilla University Hospital, Spain.
Presenting: Global Best Practice Models of Care in Prisons
Head of Viral Hepatitis and Opioid Dependency Dept., Public Health Center of the Ministry of Health of Ukraine.
Presenting: Harm Reduction and BBV Care During Wartime in Ukraine
Professor Frederick Altice
Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health.
Presenting: Enhancing BBV, harm reduction and health service coverage in prisons
Professor Barbara Broers
Professor in Addiction Medicine and vice-president of the Swiss Federal Commission for Addiction related questions and NCD, and of the Swiss Society for Cannabis in Medicine.
Presenting: Harm reduction in Switzerland, lessons learned and future challenges.
Lina Hijazi is a consultant HIV and Sexual and Reproductive Health specialist at Arud, one of the leading addiction-medicine institutions in Switzerland.
Presenting: Integrated OAT care – the example of integrating female health.
Women’s National Criminal Justice Manager, the Hepatitis C Trust.
Presenting: Community-led models for improving care in prisons: successes and challenges.
Consultant psychiatrist at the University Hospital Geneva.
Presenting: Psychedelics in addiction therapy
Plenary Abstract Speakers
Dr. Marie Jauffret-Roustide
Sociologist and Research Fellow, French National Institute of Health and Medical Research.
Presenting: Criminalisation of drug use: voices from people who inject drugs
Dr. Behzad Hajarizadeh
Clinical Epidemiologist and Associate Professor, the Kirby Institute, UNSW, Sydney.
Presenting: Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review
Dr. Andrew Seaman
Associate Professor of Medicine at Oregon Health & Sciences University, boarded in Internal and Addiction Medicine.
Presenting: Peer-facilitated telemedicine hepatitis C treatment for rural people who use drugs: results from a randomized controlled trial
Scientia Professor Louisa Degenhardt
NHMRC Senior Principal Research Fellow and Deputy Director at the National Drug and Alcohol Research Centre (NDARC), Faculty of Medicine, UNSW, Sydney.
Presenting: Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies
Professor Jason Grebely
Head of the Hepatitis C and Drug Use Group in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney.
Presenting: A national program to scale-up decentralized hepatitis C virus point-of-care testing and treatment in Australia
Mr Kennedy Kipoech
PhD student at Cape Town and Bristol universities, in SA and UK, respectively.
Presenting: HIV treatment outcomes among people who inject drugs: A global systematic review and meta-analysis